Clinical trials recruiting for SLE - Systemic Lupus Erythematosus
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CC312 | 2 |
| FT819 | 1 |
| IASO-782 injection | 1 |
| MB-CART19.1 | 1 |
| QT-019C | 1 |
| allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Nebraska | 1 |
| North Carolina | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
- Allogeneic UCB-derived CAR-T for SLE
- CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
- Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study
- IASO-782 in Systemic Lupus Erythematosus
- MB-CART19.1 in Refractory SLE
- Safety and Efficacy Study of CC312 for Moderate to Severe SLE
Related conditions
Trials recruiting for SLE - Systemic Lupus Erythematosus often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for SLE - Systemic Lupus Erythematosus trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.